Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

DR. AJAY GOGIA

Dr. Ajay Gogia, MD, DM, is an Associate Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his  M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 15 year of working and teaching experience in Medical Oncology and specializes Breast Cancer ,Non-Hodgkin’s Lymphoma and Chronic lymphocytic leukemia. He has gained  his  International exposure  in Europe , North America , UK and Canada. His research is well published with more than 150 peer reviewed articles in National and International oncology journals and is well cited. He has received Dronacharya Award in the field of Oncology for his excellence

 

Name                                                    :               Dr. Ajay Gogia  

Qualifications                                       :               MBBS,

                                                                              MD (Internal Medicine),

                                                                              DM (Medical Oncology)

 

Current Appointment                            :             Associate Professor

                                                                             Department of Medical Oncology,

                                                                             Dr. B.R.A, I.R.C.H,

                                                                             All India Institute of Medical Sciences (AIIMS)

                                                                             Ansari Nagar, New Delhi, 110029  

Nationality                                             :             Indian

 

Education and Qualifications  

Degree

University

Year

MBBS

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2000

M.D.(Internal Medicine)

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2003

D.M. (Medical Oncology)

All India Institute of Medical Sciences (AIIMS), New Delhi, India

2011

 

Working place and post  

Post

University/ INSTITUTE

Year

Senior Residency and D.M ( Medical Oncology)

All India Institute of Medical Sciences (AIIMS), New Delhi, India

2006-11

Senior Research Associate (Pool Officer)

All India Institute of Medical Sciences (AIIMS), New Delhi, India

2011-12

Assistant Professor

All India Institute of Medical Sciences (AIIMS), New Delhi, India

2013- 17

Associate Professor

All India Institute of Medical Sciences (AIIMS), New Delhi, India

2017- till date

 

Working & TEACHING experienec in medical oncology:15 years  

 Specific Area of Interest

OPD Schedule and timing

Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma especially in low grade lymphoma and CLL

Breast Cancer

 

Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday and Friday (9.30 am, Adult Medical Oncology clinic, Board Room) 

Non-Hodgkin Lymphoma  and Chronic lymphocytic leukemia  (CLL)

Thursday (2.00 pm, LL clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

 Fellowship

PLACE

Year

Indian American cancer Association-(IACA) Fellowship

Cleveland Clinic. OHIO, United States of America (USA)

Mentor: Prof. Jame Abraham

2016

European Society Of Medical Oncology (ESMO) Fellowship

Jules Bordet Hospital, Brussels

Mentor: Prof. Martine Piccart

2017

 

 MD Anderson Cancer center (MDACC)

MDACC, Houston, Texas,USA

Mentor :Prof. Hagop M.Kantarjian / Prof. Jain

2018

ESMO-  Palliative care fellowship

 

Princess Margaret Cancer Centre Toronto,Canada

Mentor : Prof. Subratha Banerjee

2019

 

Awards/Honors

PLACE

Year

Dronacharya-Award  in Oncology

New Delhi by  Minister of Health and welfare ( Mr. Ashwini Chaubey)

2019

Best Poster Award

ESMO, Barcelona Spain

2019

young investigator award

sAINTGALLEN BREAST CANCER conference,SWitzerland

2013

 

 

International Oncology Research   scholarship/grant

PLACE

Year

American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)

Sydney, Australia

2018

INDOX Cancer Research Network  

University of Oxford, United Kingdom ( UK)

2012

European Society Of Medical Oncology (ESMO)- Translational unit visit

Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)

2012

European School of Oncology –Master class in clinical Oncology

Ermatingen, Switzerland

2012

 

 

 

Observer- ship 

PLACE

Year

ESO-Short term in-house observer ship 

The Royal Marsden Hospital, London UK

2019

Short term in-house observer ship

Sarah Cannon Center, Nashville, USA

2017

 

  

Principle- Investigator ( PI)
 A Prospective, Multicentre, Phase-IV Clinical Trial of Olaparib in Indian Patients with Platinum Sensitive Relapsed Ovarian Cancer who are in Complete or Partial Response Following Platinum Based Chemotherapy and Metastatic Breast Cancer with Germline BRCA1/2 Mutation (SOLI Study)
A Prospective, Multicenter, Randomized, Double-blind, Parallel group Study to Compare the Efficacy and Safety of GBR 200 (Similar biologic of Trastuzumab) versus Innovator Trastuzumab, both when Given in Combination with Paclitaxel in Patients Diagnosed with HER2 Positive Metastatic Breast Cancer

Protocol ID: GBR 200-301

A phase II randomized study of the combination of Ribociclib plus goserelin

acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor positive/HER2-negative inoperable locally  advanced or metastatic breast cancer - RIGHT Choice Study.

Co- Investigator ( CO-PI)
A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)
A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)
A Phase III, Open Label, Randomized Multicenter Trial of Ofatumumab-Chlorambucil combination Vs. ChlorambucilMonotherapy in previously untreated patients with Chronoic Lymphocytic Leukemia”. Protocol: OMB110911. 
OMB110913 - A Phase III, Open Label, Randomized Trial of Ofatumumab added to Fludarabine-Cyclophosphamide Vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia
EGF105485 (TEACH):A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer.
ATLAS (Adjuvant Tamoxifen Long Against Short): A major international trial funded by Oxford University, UK
A randomized, multi-center, open-label, phase III study of Adjuvant Lapatinib, Trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer.” (ALTTO Study)
Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer: axis trial. Sponsored by Pfizer.
A Study of TrastuzumabEmtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA)
A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin AsFirst Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer (Protocol No. ML 25420) 
Setting up Hospital Based Cancer Registries ( HBCRs)  and  Pattern of Care and Survival Studies on Breast Cancer

 

Others

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIMS (20 in number)

International scholarship/young investigator award to present oral presentation =5

DM-Medical Oncology Teaching curriculum &  Exam Coordinator: Since 2013

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student  

Active Participation in FREE Medical Camp organized by AIIMS or Govt. of India at LEH and DHARAMSHALA

Regular Participating in patient awareness programme in DOORDARSHAN & RAJSABHA TV

CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES  

  • Members in American Society of Clinical Oncology-(ASCO ID -10476)
  • European Society of Medical Oncology- ESMO-ID-(82716)

PUBLICATIONS: (~175, Name highlighted)  

In press:

  • Gogia A,  Nigade j,  Desai C,  Govind BK,  Deshmukh C,  Swarup BTrastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer. Indian Journal of Medical and Paediatric Oncology
  • Gupta VG,  Gogia A, Kumar L  , Sharma A, et al Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural …Indian Journal of Medical and Paediatric Oncology
  • Talpua R, Kakkanattu TJ, KumarA,  Gogia A,  WigN.A Case of Idiopathic CD4 Lymphocytopenia (ICL): Immunological Mystery Leading to Storm of Diseases.

Journal of Clinical & Diagnostic Research 11 (12)

  • SVS Deo, NK Shukla, A Gogia, DN Sharma, A Jakhetiya, DK MudulyA Comparative Study of Clinical Profile and Relapse Patterns in TRIPLE-NEGATIVE and Non-Triple-Negative Breast Cancer Patients Treated with Curative IntentIndian Journal of Surgical Oncology 8 (3), 291-297
  •  Prognostic and therapeutic relevance of Phosphofructokinase platelet-type (PFKP) in Breast cancer'. Sheikh Mohammad Umar, Akansha Kashyap, Shruti Kahaol, Sandeep Mathur, Ajay Gogia, SVS Deo, Chander Prakash Experimental Cell Research 2020
  • Oligometaststic breast cancer: An Institutional Analysis :A Gogia , SVS Deo, DN Sharma, S Mathur. Indian Journal Of Cancer 2020
  • SK Chellapuram, A GogiaSystemic therapy for breast cancer during SARS-CoV-2 pandemic Cancer Research Statistics and Treatment 3(5):35
  • SK Chellapuram, A GogiaAuthors' reply to D'Souza et al.. Cancer Research, Statistics, and Treatment  2020 3 (2), 334
  • A Garg, A Gogia, S Mallick, R GuptaB-Acute lymphoblastic leukemia in a follow-up case of breast cancer Indian Journal of Medical and Paediatric Oncology 2020 41 (1), 99

 

POSTER / ORAL PRESENTATION – abstracts  

  • K Raghuram, SVS Deo, A Gogia, S Thulkar, E Dhamija, DN Sharma, Analysis of surgical and oncological outcomes of breast conservation surgery following neo adjuvant chemotherapy in locally advanced breast cancer. European Journal of Surgical Oncology 46 (6), e31
  • SC Nair, A Gogia, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathological features and outcome of diffuse large B-cell lymphoma patients treated in a resource-limited setting.Journal of Clinical Oncology 38 (15_suppl), e20062-e20062
  • A Gogia, S Nair, A Sharma, L Kumar, S Mallick, A Biswas, R Gupta Non-Hodgkin lymphoma: The Indian scene. Journal of Clinical Oncology 38 (15_suppl), e20063-e20063
  • A Gogia, S Deo, D Sharma, S Mathur. Breast cancer: The Indian scenario.Journal of Clinical Oncology 38 (15_suppl), e12567-e12567
  • SC Nair, A Gogia, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathologic features and outcome of extra-nodal diffuse large B-cell lymphoma: An institutional experience from North India.Journal of Clinical Oncology 38 (15_suppl), e20079-e20079
  • P Choudhary, A Gogia, S Deo, S Mathur, D SharmaNeoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.Journal of Clinical Oncology 38 (15_suppl), e12658-e12658
  • SK Chellapuram, A GogiaSystemic therapy for breast cancer during SARS-CoV-2 pandemic
  • Cancer Research, Statistics, and Treatment 3 (5), 35
  • R Gupta, L Rani, G Kaur, S Khan, A Gogia, A Gupta, A Sharma, L KumarmiR-223 and miR-551a as gene signatures of aggressive chronic lymphocytic leukemiaLEUKEMIA & LYMPHOMA 61, 206-207
  • S Mathur, A Johnson, SVS Deo, A Gogia, S Kahol, D Jain, V IyerPDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy LABORATORY INVESTIGATION 100 (SUPPL 1), 208-209
  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, M Kabra, A Gogia  Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia Annals of Oncology 201930   (Supplement_9), mdz427. 004
  • A Gogia, L Kumar, A Sharma, V Raina, R Gupta, L Rani. 1085P Safety and efficacy of bendamustine and rituximab (BR) regimen in Indian chronic lymphocytic leukemia patients. Annals of Oncology 30 (Supplement_5), mdz251. 020
  • A Gogia, L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055
  • N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A Gogia.  CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197
  • S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, Gogia A. ClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257
  • N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235
  • A Kakkar, S Purkait, S Agarwal, S Mallick, A Gogia, AK Karak, MC Sharma. Primary thyroid lymphoma: A series from a tertiary care center in Northern India. Journal of cancer research and therapeutics 15 (3), 669 2019
  • A Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019
  • KR Soti, L Kumar, R Saxena, S Bakhshi, A Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019
  • M Sharma, A Gogia, SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018
  • M Sharma, A Gogia, SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018
  • SK Paikaray, A Gogia, L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e1955(.2018)
  • A Biswas, L Kashyap, N Adhikari, A Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018
  • L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA). LEUKEMIA & LYMPHOMA 58, 176-177..2017
  • Bilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management. SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia L Rani, R Gupta, N Mathur, K Singh, A Gogia, D Sundar, L Kumar, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017
  • Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA) L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma. LEUKEMIA & LYMPHOMA 58, 176-177….2017
  • Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. A Jakhetiya, SS Deo, NK Shukla, A Gogia, D Sharma, D Muduly, S Mathur et.al.  ANNALS OF SURGICAL ONCOLOGY 24, S50-S50…2017
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma. SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia. European Journal of Cancer 72, S22…2017
  • 356P Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. VG Gupta, A Gogia, P Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar. Annals of Oncology 27 (suppl_9)..2016
  • 335O Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia et.al.Annals of Oncology 27 (suppl_9).. Page 586  2016
  • 256. A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A Gogia, DN Sharma, et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138
  • Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India. CK Das, L Kumar, A Gogia, R Kaushal. European Journal of Surgical Oncology 42 (9), S138..2016
  • Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.   Taywade, R Kumar, A Behera, N Damle, M Tripathi, A Gogia, CS Bal. Journal of Clinical Oncology 34 (15_suppl), e19073-e19073
  • Autologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A Gogia. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016
  • Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. A Singh, S Purkait, A Gogia, S Mallick. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. R Gupta, L Rani, N Mathur, A Gogia, D Sundar, A Sharma, L Kumar. Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146
  • RR Boya, S Bakhshi, A Gogia, RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72
  • Nasal NK-T cell lymphoma: 10-year experience of a single institute in India. P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A Gogia, T Tvsvgk. Journal of Clinical Oncology 32 (15_suppl), 19536
  • VinodRaina, Ajay Gogia, B. K. Mohanti, S. V. S. Deo, N. K. Shukla, Vishnu kumarSreenivas Breast cancer in the young (≤35 years): A single center study from the All India Institute of Medical Sciences. Journal of Clinical Oncology 31,no.15_suppl10.1200/jco.2013.31.15_suppl.e12539
  • CLINICO‐PATHOLOGICAL PROFILE AND CMYC IMMUNOREACTIVITY OF ALK POSITIVE LARGE B CELL LYMPHOMA: REPORT OF NINE CASES S Mallick, MR Lone, P Ramteke, S Purokait, A Gogia. Hematological Oncology Volume 35, Issue S2,Page 395-6
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Ritu Gupta, Lata Rani, NitinMathur, Ajay Gogia, DuraiSundar, Atul Sharma, Lalit Kumar. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia, DN Sharma, S Thulkar, S Mathur. Hematological Oncology Volume 35, Issue S2, Pages, 395-396
  • Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, Ajay Gogia, Dayanand Sharma, Sandeep R Mathur. Journal of Clinical Oncology Volume 33 e11508Publisher American Society of Clinical Oncology
  • CK Das, A Garg, A Gogia. 533P Docetaxel induced cutaneous toxicity in breast cancer patients.Annals of Oncology Volume 27Issuesuppl_9 …2016
  • Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology
  • NatarajanHarivenkatesh, Lalit Kumar, Sameer Bakhshi, Atul Sharma, MadhulikaKabra, ThirumurthyVelpandian, Ajay Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research
  • Rakesh Reddy, Atul Sharma, Sameer Bakhshi, Ajay Gogia, RanjitSahoo, ChanderPrakashYadav, Lalit Kumar. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.jOURNAL OF CLINICAL ONCOLOGY 34(15_suppl) 8024
  • SmeetaGajendra, Anita Chopra, Suman Kumar, Ajay Gogia, JaganChandramohan, Sameer Bakhshi, Atul Sharma, Lalit Kumar, Rachna Seth, RM Pandey Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.LEUKEMIA & LYMPHOMA Volume 54 Pages24-24
  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia, YK Gupta Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586
  • C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. Sharma.Prognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology Volume 27Issuesuppl_9 …2016  
  •    C.K. Das, A. GogiaN.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

  • L Kumar, P Ganess, A Gogia, I Ghosh, R Hariprasad. High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome?Biology of Blood and Marrow Transplantation Volume,16,Issue 2 Pages S239-S240
  • Sameer Taywade, Rakesh Kumar, AbhishekBehera, NishikantDamle, MadhaviTripathi, Ajay Gogia, CS Bal. Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma. Journal of Nuclear Medicine Volume 57 Issue supplement 2 Pages 1623-1623 Publisher Society of Nuclear Medicine
  • P Mehta, L Kumar, V Raina, A Sharma, S Bakhshi, A Gogia, RK Sahoo, S Pabbi, A Chopra, R Kumar high dose (18 g/m) versus low dose (12 g/m) cytosine arabinoside as consolidation for acute myeloid leukemia. Annals of Oncology 26,85
  • CK Das, L Kumar, SR Mallick, A Gogia. Prognostic significance of monocyte-lymphocyte ratio in mantle cell lymphoma.Annals of Oncology Volume 26 Issue suppl_9
  • L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, S Malik, R Gupta, OD Sharma, V Sreenivas, A GogiaAutologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome.Clinical Lymphoma, Myeloma and Leukemia Volume 15 Pages e145-e146
  • Ritu Gupta, Lata Rani, NitinMathur, Ajay Gogia, SreenivasVishnubhatla, Lalit Kumar, Atul Sharma, DivyaDubey, PunitKaur. Analysis of IGHV-DJ gene rearrangement and B-cell receptor stereotypes in chronic lymphocytic leukemia: an Indian study.LEUKEMIA & LYMPHOMA Volume 56 Pages 124-125
  • R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A Gogia. Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. International Journal of radiation Oncology.biology.Physics 96(2)E 29
  • R Reddy, S Bakhshi, A Sharma, R Sahoo, A Gogia, PS Malik, S Iqbal, Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): A prospective study.Clinical Lymphoma , Myeloma and Leukemia 15, e 171
  • Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters. S Gajendra, A Chopra, S Kumar, A Gogia, J Chandramohan, S Bakhshi, ... International Journal of Radiation Oncology• Biology• Physics 96 (2), E29
  • High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome? L Kumar, P Ganess, A Gogia, I Ghosh, R Hariprasad. Journal of Clinical Oncology 33 (15_suppl), e18013-e18013
  • A Gogia, V Raina , Sharma MC .Survival outcome of patient with primary gastric diffuse large B-cell lymphoma: An Institutional experience from developing country.Annals of Oncology 2014 Volume26 Issue suppl 4
  • A Gogia, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute. EUROPEAN JOURNAL OF CANCER 49, S846-S846
  • A Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Gajendra, Significance of smudge cell on blood smear in chronic lymphocytic leukemia patients: A prospective single institutional study from India.EUROPEAN JOURNAL OF CANCER 49, S207-S208
  • A.Gogia, A. Sharma, V. Raina, L. Kumar, R. Kumar, R. Gupta.Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia: A single-institution study of 285 cases.DOI: 10.1200/jco.2011.29.15_suppl.6584 Journal of Clinical Oncology 29, no. 15_suppl (May 2011) 6584-6584
  • Ajay Gogia, Vinod Raina, Atul Sharma, Lalit Kumar, Mehar C Sharma, Ritu Gupta, Prasenjit Das.Clinical features and outcome of follicular lymphoma: 17 years experience from All-India Institute of Medical Sciences (AIIMS), New Delhi, India. Journal of Clinical Oncology Volume31 Issue15_suppl Pages e19524-e19524 American Society of Clinical Oncology 2012
  • A Gogia, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma. Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute. EUROPEAN JOURNAL OF CANCER 49, S846-S846
  • A Gogia, V Raina, BK Mohanti, SVS Deo, NK Shukla, V Sreeniwas.Clinical significance of triple negativity in young breast cancer patients (<= 35 years): A single-institute study from India EUROPEAN JOURNAL OF CANCER 49, S315-S315 2013
  • A Gogia, V Raina, B Mohanti, S Deo, N Shukla PATTERN AND SURVIVAL OF LUNG METASTASIS IN YOUNG BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE Publication date2013/5/1. Journal Lung Cancer, Volume80,PagesS41, DBT -TRAVEL GRANT, ,WCLC, Sydney, Australia,2014
  • A Gogia, V Raina, SVS Deo, BK Mohanti, NK Shukla, S Venkat. An overview of very young breast cancer patients. The Breast, Volume21, PagesS15,SIOP-TRAVEL SCHOLARSHIP,DUBLIN 2018
  • A Gogia, V Raina, SVS Deo, BK Mohanti, NK ShuklaPROFILE OF MALE BREAST CANCER: SINGLE INSTITUTION STUDY OF 76 PATIENTS FROM NORTHERN INDIA. ANNALS OF ONCOLOGY, Volume23, Pages110-110, young investigator award,sAINTGALLEN BREAST CANCER CONFERANCE 2013.
  • A Gogia, A Sharma, V Raina, L Kumar, R Gupta, R Kumar. AN OVERVIEW OF YOUNG CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A SINGLE CENTRE EXPERIENCE OF 117 CASES FROM NORTHERN INDIA ANNALS OF ONCOLOGY, Volume 23, Pages 358-358, ICMR-TRAVEL GRANT,ESMO-2013,AMSTERDAM.

 

Book Chapters

Books

  • Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate
  • Role of Autologous Transplant in hematological Malignancies
  • Basics of Cancer Biology and Therapy:

Text book of Geriatric Medicine  

Recent Advances in Hematology

Update in Onco-Anaesthesia

 

 

 

 

 

 

 

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

 

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page